Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

10.0%

1 terminated out of 10 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

57%

4 of 7 completed with results

Key Signals

4 with results88% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (4)
P 1 (1)
P 2 (1)
P 3 (1)

Trial Status

Completed7
Withdrawn1
Recruiting1
Terminated1

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (10)

Research Network

Activity Timeline